Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Aplin

Showing results (11-20 of 156) with videos related to

Pageof 16
Sort By:
Molecular Biology of the Cell|August 22, 2008
Skp2 regulates G2/M progression in a p53-dependent mannerRong Hu, Andrew E Aplin
Pigment Cell & Melanoma Research|December 7, 2010
Mind the BAPAndrew E Aplin, Takami Sato
Molecular Cancer Research : MCR|April 12, 2011
FOXD3 regulates migration properties and Rnd3 expression in melanoma cellsPragati Katiyar, Andrew E Aplin
Nature Cancer|February 5, 2022
PROactively TACkling CDK4/6 therapy resistanceSigne Caksa, Andrew E Aplin
Pharmacological Research|March 19, 2016
Targeting mutant NRAS signaling pathways in melanomaHa Linh Vu, Andrew E Aplin
American Journal of Cancer Research|December 11, 2012
Downregulation of Noxa by RAF/MEK inhibition counteracts cell death response in mutant B-RAF melanoma cellsKevin J Basile, Andrew E Aplin
The Journal of Investigative Dermatology|December 20, 2013
Hippo: hungry, hungry for melanoma invasionIleine M Sanchez, Andrew E Aplin
Pigment Cell & Melanoma Research|May 16, 2014
Adaptive resistance to RAF inhibitors in melanomaCurtis H Kugel, Andrew E Aplin
Advances in Pharmacology (San Diego, Calif.)|September 11, 2012
Resistance to chemotherapy: short-term drug tolerance and stem cell-like subpopulationsKevin J Basile, Andrew E Aplin
Cancer Discovery|September 4, 2021
From the Community to the Bench and Back Again: The Value of Patient and Community Engagement in Cancer ResearchAmy E Leader, Andrew E Aplin
Pageof 16

Showing results (11-20 of 156) with videos related to

Sort By:
Pageof 16
Molecular Biology of the Cell|August 22, 2008
Skp2 regulates G2/M progression in a p53-dependent mannerRong Hu, Andrew E Aplin
Pigment Cell & Melanoma Research|December 7, 2010
Mind the BAPAndrew E Aplin, Takami Sato
Molecular Cancer Research : MCR|April 12, 2011
FOXD3 regulates migration properties and Rnd3 expression in melanoma cellsPragati Katiyar, Andrew E Aplin
Nature Cancer|February 5, 2022
PROactively TACkling CDK4/6 therapy resistanceSigne Caksa, Andrew E Aplin
Pharmacological Research|March 19, 2016
Targeting mutant NRAS signaling pathways in melanomaHa Linh Vu, Andrew E Aplin
American Journal of Cancer Research|December 11, 2012
Downregulation of Noxa by RAF/MEK inhibition counteracts cell death response in mutant B-RAF melanoma cellsKevin J Basile, Andrew E Aplin
The Journal of Investigative Dermatology|December 20, 2013
Hippo: hungry, hungry for melanoma invasionIleine M Sanchez, Andrew E Aplin
Pigment Cell & Melanoma Research|May 16, 2014
Adaptive resistance to RAF inhibitors in melanomaCurtis H Kugel, Andrew E Aplin
Advances in Pharmacology (San Diego, Calif.)|September 11, 2012
Resistance to chemotherapy: short-term drug tolerance and stem cell-like subpopulationsKevin J Basile, Andrew E Aplin
Cancer Discovery|September 4, 2021
From the Community to the Bench and Back Again: The Value of Patient and Community Engagement in Cancer ResearchAmy E Leader, Andrew E Aplin
Pageof 16